The generation and use of transgenic and gene-targeted mice has become an essential technology for basic cancer research, as well as for other areas of basic biomedical research. Therefore, this facility serves two critical functions within the Cancer Center. First, the Animal Facility provides convenient, affordable and high quality animal care and maintenance to Cancer Center investigators who use transgenic, mutant and other experimental mice in their research. The support for this Facility provided by the Cancer Center, as well as by the University, results in animal maintenance charges that are relatively affordable, which is a prerequisite for genetic studies using large numbers of transgenic and mutant mice. Second, the Facility operates a transgenic and chimeric mouse production service, which allows all Cancer Center investigators to generate new strains of transgenic mice or perform gene targeting (e.g., gene knockout) studies. The Facility provides technical advice on the design and construction of transgenes and gene-targeting vectors. DNA constructs for transgenesis, and genetically modified ES cell lines are produced by individual Cancer Center investigators, then delivered to the facility, where they are injected into mouse eggs or blastocysts, respectively. The resulting mice are then returned to the individual investigators for further analysis and breeding. The Facility also plans to provide cryopreservation of mouse embryos, and to produce new wild type ES cell lines for use by investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013696-28
Application #
6334895
Study Section
Project Start
2000-07-21
Project End
2001-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
2000
Total Cost
$263,834
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Ghorpade, Devram S; Ozcan, Lale; Zheng, Ze et al. (2018) Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature 555:673-677
Jauregui, Ruben; Thomas, Amanda L; Liechty, Benjamin et al. (2018) SCAPER-associated nonsyndromic autosomal recessive retinitis pigmentosa. Am J Med Genet A :
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative Comparison of Near-infrared Versus Short-wave Autofluorescence Imaging in Monitoring Progression of Retinitis Pigmentosa. Am J Ophthalmol 194:120-125
Bianchetti, E; Bates, S J; Carroll, S L et al. (2018) Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Sci Rep 8:17390
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8

Showing the most recent 10 out of 331 publications